cangrelor
Selected indexed studies
- Cangrelor in clinical use. (Future Cardiol, 2020) [PMID:32067479]
- Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives. (J Am Heart Assoc, 2021) [PMID:34212768]
- Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. (JAMA, 2012) [PMID:22253393]
_Worker-drafted node — pending editorial review._
Connections
cangrelor is a side effect of
Sources
- Cangrelor in clinical use. (2020) pubmed
- Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives. (2021) pubmed
- Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. (2012) pubmed
- Cangrelor for the treatment of patients with Arterial Thrombosis. (2018) pubmed
- The role of cangrelor in acute and high-risk PCI settings. (2025) pubmed
- Cangrelor, a newer P2Y12 inhibitor, in neuro-interventional procedures: a systematic review and updated meta-analysis. (2025) pubmed
- Cangrelor in percutaneous coronary interventions: advances in evidence, clinical applications, and future directions. (2025) pubmed
- Anti-Platelet Therapy with Cangrelor in Cardiogenic Shock Patients: A Systematic Review and Single-Arm Meta-Analysis. (2024) pubmed
- Cangrelor. (2006) pubmed
- Cangrelor in Percutaneous Coronary Intervention: Current Status and Perspectives. (2018) pubmed